Prosperity Wealth Management, Inc. Adaptimmune Therapeutics PLC Transaction History
Prosperity Wealth Management, Inc.
- $295 Billion
- Q3 2025
A detailed history of Prosperity Wealth Management, Inc. transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Prosperity Wealth Management, Inc. holds 19,227 shares of ADAP stock, worth $576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,227
Previous 19,763
2.71%
Holding current value
$576
Previous $4.74 Million
47.22%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ADAP
# of Institutions
64Shares Held
42MCall Options Held
139KPut Options Held
144K-
Long Focus Capital Management, LLC San Juan, PR18.6MShares$557,3340.1% of portfolio
-
Ubs Group Ag6.67MShares$200,0200.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.05MShares$121,6220.0% of portfolio
-
Morgan Stanley New York, NY3.67MShares$109,9810.0% of portfolio
-
Jane Street Group, LLC New York, NY2.81MShares$84,1600.0% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $4.9M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...